Sumitomo Mitsui Trust Group
BIO icon

Sumitomo Mitsui Trust Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-35,519
Closed -$8.65M – 1043
2025
Q1 		$8.65M Sell
35,519
-876
-2% -$264K 0.01% 701
2024
Q4 		$12M Sell
36,395
-1,569
-4% -$533K 0.01% 694
2024
Q3 		$12.7M Sell
37,964
-8,426
-18% -$2.68M 0.01% 689
2024
Q2 		$12.7M Sell
46,390
-4,170
-8% -$1.21M 0.01% 688
2024
Q1 		$17.5M Sell
50,560
-1,004
-2% -$330K 0.01% 726
2023
Q4 		$16.6M Sell
51,564
-2,108
-4% -$661K 0.01% 726
2023
Q3 		$19.2M Sell
53,672
-735
-1% -$284K 0.02% 706
2023
Q2 		$20.6M Sell
54,407
-7,551
-12% -$3.07M 0.02% 703
2023
Q1 		$29.7M Sell
61,958
-850
-1% -$398K 0.02% 631
2022
Q4 		$26.4M Sell
62,808
-2,695
-4% -$1.09M 0.02% 657
2022
Q3 		$27.3M Buy
65,503
+146
+0.2% +$72.8K 0.02% 648
2022
Q2 		$32.4M Sell
65,357
-1,974
-3% -$1.03M 0.02% 629
2022
Q1 		$37.9M Buy
67,331
+452
+0.7% +$272K 0.03% 611
2021
Q4 		$50.5M Sell
66,879
-50,181
-43% -$37.6M 0.03% 532
2021
Q3 		$87.3M Sell
117,060
-17,998
-13% -$13.5M 0.05% 378
2021
Q2 		$87M Buy
135,058
+1,823
+1% +$1.11M 0.05% 386
2021
Q1 		$76.1M Buy
133,235
+33,241
+33% +$19.7M 0.05% 413
2020
Q4 		$58.3M Buy
99,994
+16,568
+20% +$9.44M 0.04% 476
2020
Q3 		$43M Sell
83,426
-5,579
-6% -$2.83M 0.03% 530
2020
Q2 		$40.2M Buy
89,005
+805
+0.9% +$355K 0.03% 551
2020
Q1 		$30.9M Buy
88,200
+11,633
+15% +$4.28M 0.03% 558
2019
Q4 		$28.3M Buy
+76,567
New +$27M 0.02% 621

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Sumitomo Mitsui Trust Group's BIO Position: Q2 2025 in Review

Sumitomo Mitsui Trust Group sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 35,519 shares — an estimated $8.65M sold.

Sumitomo Mitsui Trust Group first reported a position in BIO in Q4 2019 and held it in 22 quarters. The position peaked at $87.3M in Q3 2021. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Sumitomo Mitsui Trust Group reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 35,519 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $8.65M.
  • Sumitomo Mitsui Trust Group first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 22 quarters.
  • Sumitomo Mitsui Trust Group's Bio-Rad Laboratories Class A position peaked at $87.3M in Q3 2021.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2025, filed 31 Jul 2025.